- Obama Budget Includes $38M from Generics User Fees (PharmaTimes)
- Reports: Glaxo to Cut Thousands of Jobs (Reuters)
- Sanofi-Aventis Plans to Set up Healthcare JV in China (TradingMarkets)
- FDA Issues Liver Risk Warning For Bristol-Myers HIV Drug (WITN)
- Novo Nordisk Happy with Victoza Launch as Group Sales Climb (PharmaTimes)
- Evotec and Vifor Pharma Sign Major Cooperation Agreement (CNN Money)
- Gilead Sciences Gets Notification of ANDA Filing for Viread (TradingMarkets)
- Mystery Medicine for Alzheimer’s May Yield Advance for Pfizer (Bloomberg)
- Cephalon to Buy Switzerland’s Mepha for $590 million (PharmaTimes)
- Allergan Receives FDA OK for New Juvederm Version (The New York Times)
- Spiriva Will Remain Decision Resources’ Clinical Gold Standard Through 2018 for the Treatment of Chronic Obstructive Pulmonary Disease (PR Newswire)
- 300 Branded Drug Prices Slashed in Ireland (PharmaTimes)
SUBSCRIBE